Horizon Europe is the research and innovation support programme of the EU for the period 2021-2027. It comprises 3 pillars:
- Pillar 1 Excellent science
- Pillar 2 Global challenges & European Industrial Competitiveness
- Pillar 3 European Industrial Competitiveness
Under Pillar 2: Cluster 1 ‘Health’ aims to mainly contribute to four impact areas of the strategic plan:
- Good health and high-quality accessible healthcare
- Resilient EU prepared for emerging threats
- High quality digital services for all
- Competitive and secure data-economy
More specifically, cluster 1 aims to contribute to six expected impacts as set by the strategic plan, which are the destinations of this work programme:
- Destination 1: Staying healthy in a rapidly changing society
- Destination 2: Living and working in a health-promoting environment
- Destination 3: Tackling diseases and reducing disease burden
- Destination 4: Ensuring access to innovative, sustainable and high-quality health care
- Destination 5: Unlocking the full potential of new tools, technologies and digital solutions for a healthy society
- Destination 6: Maintaining an innovative, sustainable and globally competitive health industry
The Horizon Europe Health cluster is mainly implemented through annual calls for proposals for Research and Innovation Actions (RIA), Innovation Actions (IA), Cofund actions, Coordination and Support Actions (CSA), pre-commercial procurement (PCP) actions and public procurement of innovative solutions (PPI), as well as emergency calls for Expressions of Interest in response to emergencies.
Legacy - Horizon 2020 (2014-2020)
The legacy programme “Horizon 2020 – Societal challenge 1: Health, Demographic change and Wellbeing” is part of Pillar 2 of Horizon 2020 (2014-2020); the others being Excellent Science and Industrial Leadership as ‘mutually reinforcing priorities’.
The main objective of the Societal Challenge 1 (SC1) - Health, Demographic change and Wellbeing actions are to support health research and innovation from bench to bedside to translate science to benefit citizens and European healthcare sector; to ensure the rapid transfer of knowledge and innovative solutions into prevention, diagnosis, treatment modalities and healthcare in Europe and around the globe; and to promote healthy and active ageing. In doing so, it contributes to the broader objectives of ensuring better health for all and a more competitive health and care sector. Horizon 2020 SC1 is mainly implemented through Research and Innovation Actions (RIA), Innovation Actions (IA), Coordination and Support Actions (CSA) and Cofunds. It also used novel funding instruments, notably lump sums, pre-commercial procurement (PCP) actions and public procurement of innovative solutions (PPI). Emergency calls for Expressions of Interest were also launched in response to infectious diseases outbreaks: Ebola, Zika and, lately Covid-19.